“Our Center for Reproductive Medicine has long had specialists to diagnose and treat female infertility. With the addition of Dr. Jaffe, we now have someone who specializes in male infertility, making the full continuum of care available under one roof,” Stanley Zaslau, M.D., M.B.A., chairman of WVU Medicine Urology, said. “We are honored that Dr. Jaffe has joined our team and proud to be able to offer these services to our patients.”
Jaffe came to WVU Medicine from the University of Pittsburgh Medical Center, where he was director of male reproductive medicine and surgery. He received his medical degree from Case Western Reserve University in Cleveland, Ohio. He then completed residencies in general surgery and urology at Boston University.
During his residency, Jaffe developed an interest in male infertility, erectile dysfunction, and Peyronie’s disease, which prompted his decision to receive fellowship training in male reproductive medicine and surgery at Baylor University in Houston, Texas. His fellowship training included microsurgical reconstruction of the male reproductive tract, including vasectomy reversal.
According to the Centers for Disease Control and Prevention, a male factor is identified along with a female factor in approximately 35 percent of couples with infertility. A male factor is the only identifiable cause in about 8 percent of couples. In addition, almost 9 percent of men age 25-44 in the U.S. reported that they or their partner sought out a doctor for advice, testing, or treatment for infertility during their lifetime.
A man’s risk of infertility increases as a result of:
- Age (40 years old or older)
- Being overweight or obese
- Excessive alcohol use
- Use of marijuana
- Exposure to testosterone, radiation, environmental toxins, certain medications, and frequent exposure of the testes to high temperatures
To schedule an appointment with Jaffe, call 855-WVU-CARE (855-988-2273).
WVU Heart and Vascular Institute among top sites in innovative pilot study to improve outcomes of heart attacks
The WVU Heart and Vascular Institute was a leading site in a national pilot study assessing a new treatment for patients experiencing a myocardial infarction, or heart attack. The door to unload (DTU) trial was presented yesterday (Oct. 11) as a late breaking clinical trial at the American Heart Association Scientific Sessions 2018.
The WVU Cancer Institute is among six organizations to receive an inaugural Medline Breast Cancer Awareness grant, which is awarded to organizations to further the mission to eradicate breast cancer and provide counseling. The grant drives awareness around prevention and early detection by providing support to organizations that provide direct patient care.
The 20th Annual Lacy Neff Q for Kids Radiothon benefitting WVU Medicine Children’s will be on Wednesday, Nov. 14, in conjunction with the second annual WVU Day of Giving.